Perindopril Protection Against Recurrent Stroke Study "PROGRESS"

Completed

Phase N/A Results

Summary of Purpose

To compare the angiotensin-converting enzyme (ACE) inhibitor perindopril, alone or in combination with the diuretic indapamide, to placebo in the secondary prevention of stroke and other major cardiovascular events.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 March 2010.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Health Research Council of New Zealand, National Health and Medical Research Council of Australia, Institut de Recherches Internationales Servier

Trial Design

Randomized, double-blind, placebo-controlled, international, trial of 6105 patients at 172 centers.

Contacts

Not available